BUSINESS
Cipla climbs on reporting 45% rise in Q2 consolidated net profit
Cipla is currently trading at Rs. 1178.10, up by 27.95 points or 2.43% from its previous closing of Rs. 1150.15 on the BSE. The scrip opened at Rs.…
cipla
BUSINESS
Cipla inches up as its arm inks definitive agreements to acquire Endura Mass
Cipla is currently trading at Rs. 953.60, up by 2.75 points or 0.29% from its previous closing of Rs. 950.85 on the…
BUSINESS
Cipla inches up on signing definitive agreements for acquisition of 21.05% stake in Achira Labs
Cipla is currently trading at Rs. 917.10, up by 1.50 points or 0.16% from its previous closing of Rs. 15.60 on the…
BUSINESS
Cipla, DNDi launch child-friendly 4-in-1 antiretroviral treatment in South Africa
Cipla and not-for-profit Drugs for Neglected Diseases initiative (DNDi) have launched child-friendly 4-in-1 antiretroviral treatment for young children living with HIV in…
BUSINESS
Cipla moves up on reporting marginal rise in Q3 consolidated net profit
Cipla is currently trading at Rs. 911.15, up by 7.05 points or 0.78% from its previous closing of Rs. 904.10 on the…
BUSINESS
Cipla trades in green on the BSE
Cipla is currently trading at Rs. 923.50, up by 16.65 points or 1.84% from its previous closing of Rs. 906.85 on the…
BUSINESS
Cipla trades in green on getting Emergency Use Authorisation to launch oral antiviral drug Cipmolnu in India
Cipla is currently trading at Rs. 932.10, up by 2.65 points or 0.29% from its previous closing of Rs. 929.45 on the…